Inventor · disambiguated record
Francis C. Brunicardi
Also filed as: BRUNICARDI FRANCIS C · BRUNICARDI FRANCIS CHARLES
5 granted patents·4 pending applications·8 citations·filing 2013–2024
70Inventor score
Top patents by PatentIndex Score
9 records- 0179US9644205B2Synthetic promoter for modulating gene expressionUNIV CALIFORNIA·Filed 2013·Granted May 9, 2017·5 cites·10 claims
- 0277US11197844B2Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancerUNIV CALIFORNIA·Filed 2020·Granted Dec 14, 2021·1 cites·15 claims
- 0377US11060087B2Synthetic promoters for high throughput screening and gene modulationUNIV CALIFORNIA·Filed 2017·Granted Jul 13, 2021·2 cites·13 claims
- 0470US2024398974A1Smart Exosomes for Active PDAC Targeting and Evading Mononuclear Phagocytotic SystemUNIV TOLEDO·Filed 2024·Application pending·0 cites
- 0568US12090213B2Smart exosomes for active PDAC targeting and evading mononuclear phagocytotic systemUNIV TOLEDO·Filed 2022·Granted Sep 17, 2024·0 cites·14 claims
- 0654US2024150279A1C prime agents for treating metabolic disordersUNIV TOLEDO·Filed 2022·Application pending·0 cites
- 0750US2024374628A1Triple Drug Combination (Metformin, Simvastatin, Digoxin) for Targeted Treatment of Colorectal CancerWHISPERGENICS INC·Filed 2022·Application pending·0 cites
- 0847US2022151976A1Targeting lasp1, eif4a1, eif4b and cxc4 with modulators and combinations thereof for cancer therapyUNIV TOLEDO·Filed 2020·Application pending·0 cites
- 0945US10813909B2Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancreatic cancerUNIV CALIFORNIA·Filed 2017·Granted Oct 27, 2020·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Francis C. Brunicardi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →